Minimizing the Burden of Prior Authorization in AMD Through Actionable Strategies and Improved Communication
| Overview / Abstract: |
The development of anti–vascular endothelial growth factor (VEGF) agents has revolutionized the treatment of age-related macular degeneration (AMD). Nevertheless, optimal management of AMD is impeded by challenges in access to FDA-approved therapies. Step therapy, a type of prior authorization (PA) instituted by the payer, mandates that more cost-effective therapies be used before more expensive alternatives, in a stepwise approach. However, applying this strategy to vision-threatening diseases such as AMD often leads to treatment delays and increases the risk of disease progression. In order to decrease the burden of PA for AMD treatments, the second module of this CME Outfitters Snack series aims to provide learners with strategies to improve documentation and establish clear communication with the payer to minimize treatment delays. |
|
Expiration |
Nov 21, 2020 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Optometry / Ophthalmology CE, Pharmacy CPE, Physician CME, Physician Assistant CME |
|
Format |
Online, Webinar / Webcast / Video |
|
Credits / Hours |
0.5 AMA PRA Category 1 Credit(s)™/contact hours/CEUs |
|
Accreditation |
ACCME, AANP, APCE, AAPA, ABO, RCPSC, MACRA |
|
Presenters / Authors / Faculty |
Darius M. Moshfeghi, MD Derek van Amerongen, MD, MS |
|
Sponsors / Supporters / Grant Providers |
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. |
|
Keywords / Search Terms |
CME Outfitters, LLC ophthalmology, optometry, optical, retinal, AMD, macular degeneration Free CE CME |
|